Post by
thadeush on Jul 29, 2022 8:56pm
Split the company?
probably premature at this point, but assuming (like we all are) the bladder cancer treatment gets the results we expect, would it be smart for TLT to split the cancer treatment part of the company and the vaccine part? Just thinking out loud, but with laser therapy and cancer treatment and vaccine/virus treatment TLT may be getting a bit confusing for the market. It also might maximize profits as each part has incredible potential on its own. Thoughts? (sorry if this has already been discussed)
Comment by
Oilminerdeluxe on Jul 30, 2022 1:58am
So, is the belief that we will have both new cancer data and a vaxx update sometime in August? Would not mind seeing an improvement in the CR numbers. I guess that goes for us all, he he. It would be easier to commit more money for shares if things improve. Odds for it to happen must be good at least.
Comment by
ScienceFirst on Jul 30, 2022 10:06am
Feb. 7 news release mentioned Q4 for an update from NML regarding the COVID-19 indication. Q4 start Oct. 1st.
Comment by
Pandora on Jul 30, 2022 12:33pm
Yes, the words "be completed by 4Q2022'" certainly suggests it could be in September or ??
Comment by
Rumpl3StiltSkin on Jul 31, 2022 9:25am
Slayer, I believe Canada will fast track this, given it's importance. How they do it is the Question.
Comment by
Rumpl3StiltSkin on Jul 30, 2022 12:00pm
Ah, Q4... Well, at least we'll know prior to EoY...